< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

3 clusters · 8 sources · 19 days · First seen · Last updated

Bayer Roundup litigation and settlement efforts

Overview

Bayer continues to face legal and financial challenges regarding its herbicide Roundup and allegations that its active ingredient, glyphosate, causes non-Hodgkin lymphoma.

In the United States, a Missouri court is conducting a fairness hearing regarding a proposed $7.25 billion settlement. While previous estimates addressed approximately 65,000 claims, the current settlement aims to resolve litigation involving approximately 197,000 Americans. If approved, the deal would provide between $10,000 and $165,000 for affected individuals.

However, the settlement faces opposition from some plaintiffs’ attorneys who have characterized the deal as a ‘collusive arrangement.’ These objectors argue that the framework provides significant fees to attorneys while offering relatively small payouts to victims. They have also criticized the settlement for allowing Bayer to continue selling the product without cancer warnings and for limiting future punitive damages through a 20-year claims period. Bayer maintains that glyphosate is safe and denies all allegations of wrongdoing.

In Chile, the legal battle has taken a different turn. The Supreme Court rejected a cassation appeal by the Organization of Consumers and Users (ODECU), ending a five-year class action lawsuit against Bayer and Arysta LifeScience. Following the dismissal, ODECU has called on Bayer to voluntarily implement compensation and assistance mechanisms for affected individuals, similar to the programs established by the company in the United States.

Entities

Bayer · Monsanto · Roundup · Arysta LifeScience · Timothy Boyer

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. about 23 hours ago

    [BUSINESS] 4 sources
    Bayer glyphosate settlement faces US court fairness hearing

    A Missouri court is reviewing a proposed $7.25 billion settlement by Bayer to resolve Roundup glyphosate litigation involving nearly 200,000 claimants.

  2. 4 days ago

    [BUSINESS] 2 sources
    Bayer seeks approval for $7.25 billion Roundup settlement

    Bayer seeks court approval for a $7.25 billion settlement to resolve tens of thousands of U.S. lawsuits alleging Roundup causes non-Hodgkin lymphoma, with individual payouts varying by severity.

  3. 20 days ago

    [BUSINESS] 2 sources
    Bayer faces calls for voluntary compensation after Chile court rejects Roundup lawsuit

    Chile's Supreme Court dismissed a class action lawsuit against Bayer and Arysta regarding Roundup's alleged links to cancer, prompting consumer advocates to call for voluntary compensation models.

Sources

faz.net · finanzen.net · finde.latercera.com · insurancejournal.com · it-boltwise.de · portalfruticola.com · thenewlede.org · thepricer.org

This summary has been updated 1 time: see revision history